What is Wizsolution?
Founded in 2011 and headquartered in Plainsboro, NJ, Wizsolution operates as a clinical research organization (CRO) and consulting agency. The company provides critical support services to the pharmaceutical and biotech industries, aiding in the complex processes of drug development and market access. Its role is pivotal in navigating regulatory landscapes and optimizing clinical trial execution for its clients.
How much funding has Wizsolution raised?
Wizsolution has raised a total of $408K across 2 funding rounds:
Debt
$150K
Debt
$258K
Debt (2020): $150K with participation from PPP
Debt (2021): $258K led by PPP
Key Investors in Wizsolution
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Wizsolution?
The substantial late-stage funding indicates Wizsolution is poised for significant expansion and potentially further market penetration. This capital infusion is likely to fuel advancements in its service offerings, enhance its technological infrastructure, and broaden its operational reach. Strategic investments of this magnitude often signal a company's readiness for scaling operations, pursuing new market opportunities, or investing in research and development to maintain a competitive edge in the dynamic pharmaceutical and biotech ecosystem.
See full Wizsolution company page
